Sort
34,240 grants matching “atherosclerosis”
CONTROL OF CHOLESTEROL METABOLISM -- BILE ACID TRANSPORT
$725,103University Of Texas Sw Med Ctr/Dallas · R37 · FY2001 · HL
Diabetes Prevention Program Outcomes Study - Phase 2
$724,992F. Xavier Pi-Sunyer · St. Luke'S-Roosevelt Inst For Hlth Scis · U01 · FY2013 · DK
Comprehensive CT Guided Coronary Artery Bypass Graft Surgery
$724,992Koen Nieman · Stanford University · R01 · FY2022 · HL
Dietary Mitigation of Psychosocial Stress Effects on CVD Risk
$724,975Carol A. Shively · Wake Forest University Health Sciences · R01 · FY2014 · HL
Effects of Anti-miR-33 on Atherosclerosis Regression and RCT in Nonhuman Primates
$724,972Ryan Eugene Temel · University Of Kentucky · R01 · FY2015 · HL
Experimental Pathology of Cardiovascular Disease
$724,917Stephen Mark Schwartz · University Of Washington · T32 · FY2018 · HL
Significance of Atrial Fibrillation and Atrial Fibrillation Burden Detected by Novel ECG Monitoring in Community-Dwelling Elderly
$724,836Lin Yee Chen · University Of Minnesota · R01 · FY2018 · HL
The Penn State Child Sleep Cohort: Cardiometabolic and Neurocognitive Risk in Young Adulthood
$724,807Julio Fernandez-Mendoza · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2021 · HL
Clinical and Genetic Correlates of Vascular Function in African Americans: JHS
$724,579Ervin R Fox · University Of Mississippi Med Ctr · R01 · FY2014 · HL
Impact of L. plantarum 299v Supplementation on Endothelial Function and Systemic Inflammation
$724,304Michael E Widlansky · Medical College Of Wisconsin · R01 · FY2019 · HL
Whole Genome Association Analysis of the Diabetes Heart Study
$724,275Donald W. Bowden · Wake Forest University Health Sciences · R01 · FY2010 · HL
Precision Medicine for Therapeutic Angiogenesis in Peripheral Arterial Disease: Targeting of the IL21R Pathway
$724,231Brian H Annex · Augusta University · R01 · FY2022 · HL
Improving Risk Stratification in Familial Hypercholesterolemia (RISK-FH)
$724,211Matthew Oetjens · Geisinger Clinic · R01 · FY2024 · HL
Lifecourse CVD Risk and Midlife Cognitive Trajectories and Brain Aging: Implications for Alzheimer's and Dementia Prevention
$724,187Kristine Yaffe · Northern California Institute/Res/Edu · R01 · FY2022 · AG
The Integrative Social Relations, Health and Aging Project
$724,154John T. Cacioppo · University Of Chicago · R01 · FY2009 · AG
Gene Therapy in Hutchinson-Gilford Progeria Syndrome
$724,153Jonathan David Brown · Vanderbilt University Medical Center · R01 · FY2023 · HL
Gene Therapy in Hutchinson-Gilford Progeria Syndrome
$724,153Jonathan David Brown · Vanderbilt University Medical Center · R01 · FY2025 · HL
MECHANISMS UNDERLYING THE AGE-RELATED ATHEROPROTECTIVE EFFECTS OF HORMONE THERAPY
$724,027Howard N Hodis · University Of Southern California · R01 · FY2020 · AG
MECHANISMS UNDERLYING THE AGE-RELATED ATHEROPROTECTIVE EFFECTS OF HORMONE THERAPY
$724,027Howard N Hodis · University Of Southern California · R01 · FY2022 · AG
MECHANISMS UNDERLYING THE AGE-RELATED ATHEROPROTECTIVE EFFECTS OF HORMONE THERAPY
$724,027Howard N Hodis · University Of Southern California · R01 · FY2018 · AG
MECHANISMS UNDERLYING THE AGE-RELATED ATHEROPROTECTIVE EFFECTS OF HORMONE THERAPY
$724,027Howard N Hodis · University Of Southern California · R01 · FY2019 · AG
MECHANISMS UNDERLYING THE AGE-RELATED ATHEROPROTECTIVE EFFECTS OF HORMONE THERAPY
$724,027Howard N Hodis · University Of Southern California · R01 · FY2021 · AG
Glucose homeostasis and the risk of Alzheimer's disease and Alzheimer's disease related dementias in the Multi-Ethnic Study of Atherosclerosis
$724,004Morgana Lee Mongraw-Chaffin · Medstar Health Research Institute · R01 · FY2024 · AG
Quantitative Trait Locus Mapping in Human Pedigrees
$723,954John Blangero · Texas Biomedical Research Institute · R37 · FY2008 · MH
Clinical Phenotyping and Disease Specific Sampling to Identify Non-coding RNAs for Human Therapeutics in PAD
$723,849Brian H Annex · Augusta University · R01 · FY2023 · HL